- Home
- LDI vs OABI Comparison
LDI vs OABI Comparison
Compare LDI & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDI
- OABI
- Stock Information
- Founded
- LDI 2010
- OABI 2012
- Country
- LDI United States
- OABI United States
- Employees
- LDI N/A
- OABI N/A
- Industry
- LDI Finance: Consumer Services
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- LDI Finance
- OABI Health Care
- Exchange
- LDI Nasdaq
- OABI Nasdaq
- Market Cap
- LDI 221.2M
- OABI 185.9M
- IPO Year
- LDI 2021
- OABI N/A
- Fundamental
- Price
- LDI $1.31
- OABI $1.27
- Analyst Decision
- LDI Sell
- OABI Strong Buy
- Analyst Count
- LDI 3
- OABI 3
- Target Price
- LDI $1.98
- OABI $7.00
- AVG Volume (30 Days)
- LDI 735.5K
- OABI 814.0K
- Earning Date
- LDI 05-06-2025
- OABI 05-08-2025
- Dividend Yield
- LDI N/A
- OABI N/A
- EPS Growth
- LDI N/A
- OABI N/A
- EPS
- LDI N/A
- OABI N/A
- Revenue
- LDI $1,090,719,000.00
- OABI $26,744,000.00
- Revenue This Year
- LDI $28.75
- OABI N/A
- Revenue Next Year
- LDI $15.05
- OABI $40.06
- P/E Ratio
- LDI N/A
- OABI N/A
- Revenue Growth
- LDI 21.07
- OABI 27.07
- 52 Week Low
- LDI $1.01
- OABI $1.22
- 52 Week High
- LDI $3.23
- OABI $4.96
- Technical
- Relative Strength Index (RSI)
- LDI 60.49
- OABI 27.15
- Support Level
- LDI $1.18
- OABI $1.35
- Resistance Level
- LDI $1.36
- OABI $1.41
- Average True Range (ATR)
- LDI 0.08
- OABI 0.09
- MACD
- LDI 0.02
- OABI 0.00
- Stochastic Oscillator
- LDI 81.48
- OABI 12.20
About LDI loanDepot Inc.
loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It also provides online mortgage loans for refinancing and home purchases. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.